Login / Signup
The presumed protective effect of IVIG against SARS-CoV-2 in inflammatory myopathy patients remains questionable.
Finsterer Josef
Fulvio Alexandre Scorza
Published in:
Rheumatology international (2023)
Keyphrases
</>
sars cov
end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
peritoneal dialysis
prognostic factors
oxidative stress
patient reported outcomes
respiratory syndrome coronavirus
muscular dystrophy